A Diagnostic Model With IgM Autoantibodies and Carcinoembryonic Antigen for Early Detection of Lung Adenocarcinoma.

Abstract

Immunoglobulin M (IgM) autoantibodies, as the early appearing antibodies in humoral immunity when stimulated by antigens, might be excellent biomarkers for the early detection of lung cancer (LC). We aimed to develop a multi-analyte integrative model combining IgM autoantibodies and a traditional tumor biomarker that could be a valuable and powerful auxiliary diagnostic tool and might improve the accuracy of early detection of lung adenocarcinoma (LUAD). A customized protein array based on cancer driver genes was constructed and applied in the discovery cohort consisting of 68 LUAD patients and 68 normal controls (NCs); 31 differentially expressed IgM autoantibodies were identified. The top 5 candidate IgM autoantibodies [based on the area under the receiver operating characteristic curve (AUC) ranking], namely, TSHR, ERBB2, survivin, PIK3CA, and JAK2, were validated in the validation cohort using enzyme-linked immunosorbent assay (ELISA), which included 147 LUAD samples, 72 lung squamous cell carcinoma (LUSC) samples, 44 small cell lung carcinoma (SCLC) samples, and 147 NCs. These indicators presented diagnostic capacity for LUAD, with AUCs of 0.599, 0.613, 0.579, 0.601, and 0.633, respectively (p < 0.05). However, none of them showed a significant difference between the SCLC and NC groups, and only the IgM autoantibody against JAK2 showed a higher expression in LUSC than in NC (p = 0.046). Through logistic regression analysis, with the five IgM autoantibodies and carcinoembryonic antigen (CEA), one diagnostic model was constructed for LUAD. The model yielded an AUC of 0.827 (sensitivity = 56.63%, specificity = 93.98%). The diagnostic efficiency was superior to that of either CEA (AUC = 0.692) or IgM autoantibodies alone (AUC = 0.698). Notably, the accuracy of this model in early-stage LUAD reached 83.02%. In conclusion, we discovered and identified five novel IgM indicators and developed a multi-analyte model combining IgM autoantibodies and CEA, which could be a valuable and powerful auxiliary diagnostic tool and might improve the accuracy of early detection of LUAD.

• Authors: Xue Zhang, Jiaqi Li, Yulin Wang, Man Liu, Fenghui Liu, Xiuzhi Zhang, Lu Pei, Tingting Wang, Di Jiang, Xiao Wang, Jianying Zhang, Liping Dai
• Journal: Frontiers in immunology (Front Immunol) Vol. 12 Pg. 728853 ( 2021) ISSN: 1664-3224 [Electronic] Switzerland
• PMID: 35140701 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2022 Zhang, Li, Wang, Liu, Liu, Zhang, Pei, Wang, Jiang, Wang, Zhang and Dai.

Chemical References

• Antigens, Neoplasm
• Autoantibodies
• Biomarkers, Tumor
• Carcinoembryonic Antigen
• Immunoglobulin M

Topics

• Adenocarcinoma of Lung (immunology)
• Adult
• Aged
• Aged, 80 and over
• Antigens, Neoplasm (immunology)
• Autoantibodies (immunology)
• Biomarkers, Tumor (immunology)
• Carcinoembryonic Antigen (immunology)
• Carcinoma, Squamous Cell (immunology)
• Early Detection of Cancer (methods)
• Female
• Humans
• Immunoglobulin M (immunology)
• Lung Neoplasms (immunology)
• Male
• Middle Aged
• Oncogenes (immunology)
• ROC Curve